Registry study for certain ovarian and testicular tumors
Part of Cancer clinical trials.
This study collects information from people who have had specific types of ovarian or testicular stromal tumors. It does not test a new drug; it helps doctors understand these rare tumors better over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have (or have had) an ovarian sex cord stromal tumor such as Sertoli-Leydig, juvenile granulosa, Sertoli cell, or similar types
- Or you have (or have had) a testicular stromal tumor such as juvenile granulosa, Sertoli cell, Leydig cell, or similar types
- If you are an adult with granulosa cell tumor, you may be excluded unless the study’s medical director says otherwise
- You (or your child) can provide consent or assent to join the registry
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This registry collects information about people with known or suspected DICER1-related conditions, including certain rare chest and other tumor types. It helps doctors and researchers understand these conditions better and may support future studies.
This study collects DNA and medical information to better understand germ cell and testicular tumors and possible inherited genetic causes. It may help researchers sort out how genetic changes relate to these cancers, even if you’re not receiving a new drug.
This is a research study that builds a registry (a record) of women in Korea with cervical, endometrial, or ovarian cancer. It may help researchers better understand these cancers and plan future studies.
This is a study that collects information about people with rare cancers (or cancers where the source is unknown) and advanced-stage cancer. It helps researchers build a knowledge database to improve understanding and care for these cancers in Asia.
This registry collects information from people with advanced ovarian or endometrial cancer to better understand care and outcomes. It may help researchers and doctors learn which treatments work best for different patients.
This study is watching and collecting data from patients with rare gynecologic tumors. It uses special tests on your tumor samples to learn more about these cancers, which may help find better treatments in the future.
Hear when a new Ovarian Sex-cord Stromal Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.